SLC6A3 and Parkinson disease: Consistent with recent reports20,67,68, these data support the interpretation that dopaminergic proteins may mediate immune functions in PBMCs, and that PBMCs expressing DAT and TH may delineate PD in human patients relative to healthy controls.